{"date":"2026-09-04","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6446-2026-09-04-1938-dkzfhk","company_id":"6446","company":"藥華藥","market":"上市","industry":"生技醫療","date":"2026-09-04","time":"19:38:10","subject":"本公司受邀參加Wells Fargo舉辦之法說會「21st Annual Healthcare Conference」","clause":"第12款","fact_date":"2026-09-10","cite_as":"公開資訊觀測站重大訊息：藥華藥（6446），2026-09-04 19:38，「本公司受邀參加Wells Fargo舉辦之法說會「21st Annual Healthcare Conference」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-09-04-1902-ntu6lr","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-09-04","time":"19:02:28","subject":"公告本公司董事會決議買回庫藏股事宜。","clause":"第41款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-09-04 19:02，「公告本公司董事會決議買回庫藏股事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-09-04-1724-lzscd5","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-09-04","time":"17:24:46","subject":"本公司受邀參加由富邦證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-09-09","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-09-04 17:24，「本公司受邀參加由富邦證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-09-04-1645-6j2n9d","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-09-04","time":"16:45:52","subject":"本公司註銷買回庫藏股辦理完成","clause":"第36款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-09-04 16:45，「本公司註銷買回庫藏股辦理完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-09-04-1637-d2kg2i","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-09-04","time":"16:37:06","subject":"公告本公司董事會決議召開115年股東臨時會相關事宜","clause":"第32款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-09-04 16:37，「公告本公司董事會決議召開115年股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-09-04-1616-k3qv66","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-09-04","time":"16:16:17","subject":"代子公司Handa Oncology, LLC公告與505(b)(2)新藥HND-039 Omcazio有關之訴願案，已由美國FDA駁回","clause":"第53款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-09-04 16:16，「代子公司Handa Oncology, LLC公告與505(b)(2)新藥HND-039 Omcazio有關之訴願案，已」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-09-04-1609-j10t6y","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-09-04","time":"16:09:25","subject":"公告調整本公司與Sunway Health, Inc.進行股份交換案之股份交換基準日","clause":"第9款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-09-04 16:09，「公告調整本公司與Sunway Health, Inc.進行股份交換案之股份交換基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-09-04-1604-41cf5f","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-09-04","time":"16:04:19","subject":"公告本公司董事會決議擬辦理私募發行普通股案","clause":"第9款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-09-04 16:04，「公告本公司董事會決議擬辦理私募發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-09-04-1509-1xkemff","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-09-04","time":"15:09:12","subject":"本公司接獲可成科技(股)公司通知，依據公司法第369條之8規定公告股權變動事宜(取得本公司已發行股份總數超過三分之一以上)","clause":"第33款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-09-04 15:09，「本公司接獲可成科技(股)公司通知，依據公司法第369條之8規定公告股權變動事宜(取得本公司已發行股份總數超過三分之一以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-09-04-1457-14e32ox","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-09-04","time":"14:57:24","subject":"公告本公司董事會通過辦理現金增資發行新股","clause":"第11款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-09-04 14:57，「公告本公司董事會通過辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2026-09-04-1453-ffkv0w","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2026-09-04","time":"14:53:59","subject":"本公司限制員工權利新股收回註銷減資變更登記完成","clause":"第35款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2026-09-04 14:53，「本公司限制員工權利新股收回註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-09-04-1447-d3cofy","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-09-04","time":"14:47:02","subject":"公告本公司財務主管、會計主管、公司治理主管、代理發言人異動","clause":"第8款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-09-04 14:47，「公告本公司財務主管、會計主管、公司治理主管、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-09-04-0700-1i5dhci","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-09-04","time":"07:00:59","subject":"代子公司 Handa Oncology, LLC 公告治療癌症之505(b)(2) 新藥 HND-039 OMCAZIO 通過美國FDA新藥藥證審查，取得最終核准(Final Approval)","clause":"第53款","fact_date":"2026-09-04","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-09-04 07:00，「代子公司 Handa Oncology, LLC 公告治療癌症之505(b)(2) 新藥 HND-039 OMCAZIO」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-09-04-0622-1t50q23","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-09-04","time":"06:22:33","subject":"代重要子公司Acepodia Biotech, Inc.公告研發中之ADC新藥ACE723第一期臨床試驗，通過美國FDA IND審查。","clause":"第8款","fact_date":"2026-09-03","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-09-04 06:22，「代重要子公司Acepodia Biotech, Inc.公告研發中之ADC新藥ACE723第一期臨床試驗，通過美國FDA」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}